Corbin Capital Partners »

Arbutus Biopharma shares owned by Corbin Capital Partners

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Corbin Capital Partners from 13F filings

Historical chart of Corbin Capital Partners investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Corbin Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Corbin Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.2M 853k 2.58

More positions owned by Corbin Capital Partners

Euronav Nv SHS (CMBT)
TDCX Ads (TDCX)
Core Scientific Note 10.000% 1/2
Indivior Ord (INDV)
Core Scientific (CORZ)
Arbutus Biopharma (ABUS)
Odyssey Marine Expl Com New (OMEX)
Roivant Sciences SHS (ROIV)
Alpha Tau Medical Ordinary Shares (DRTS)
Hippo Hldgs Com New (HIPO)
Terran Orbital Corporation (LLAP)
Metals Acquisition *w Exp 06/15/202
Alpha Tau Medical *w Exp 99/99/999 (DRTSW)
Ree Automotive Shs Cl A New (REE)
Hertz Global Hldgs Com New (HTZ)

View all positions for Corbin Capital Partners

Top funds holding Arbutus Biopharma

Morgan Stanley
Whitefort Capital Management
BlackRock
Two Seas Capital
Vanguard Group
Geode Capital Management
State Street Corporation
BlackBarn Capital Partners
Citigroup
Hudson Bay Capital Management
Rubric Capital Management
Squarepoint Ops
Woodline Partners
Susquehanna International
Saba Capital Management

View all funds holding Arbutus Biopharma